🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 96 of 116

  1. Fostamatinib 100 mg bid and Paclitaxel

    RIGEL PHARMACEUTICALS INC

    Ovarian Cancer

    phase 1 small molecule completed

    1 trial

  2. Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)

    RIGEL PHARMACEUTICALS INC

    Pancreatic Ductal Adenocarcinoma (PDAC)

    phase 1 other active

    1 trial

  3. Furmonertinib

    ArriVent BioPharma

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  4. G207

    BRIGHT MINDS BIOSCIENCES INC.

    Supratentorial Neoplasms, Malignant

    phase 1 mab completed

    1 trial

  5. GB-4362

    Generate Biomedicines

    Advanced Urothelial Cancer

    phase 1 small molecule active

    1 trial

  6. GB-5267 - IV only

    Generate Biomedicines

    Platinum-resistant Ovarian Cancer

    phase 1 mab active

    1 trial

  7. GC4419

    Galera Therapeutics

    Squamous Cell Carcinoma of the Oral Cavity

    phase 1 small molecule completed

    1 trial

  8. GCAR1

    Chongqing Precision Biotech Co., Ltd

    Sarcoma

    phase 1 mab active

    1 trial

  9. GCC2005

    Artiva Biotherapeutics

    Lymphoma, T-Cell

    phase 1 small molecule active

    1 trial

  10. GDC-0084

    KAZIA THERAPEUTICS LTD

    Brain and Central Nervous System Tumors

    phase 1 small molecule completed

    1 trial

  11. GEN1042

    Genmab A/S

    Malignant Solid Tumor

    phase 1 mab active

    1 trial

  12. GK01 Injection

    The First People's Hospital of Lianyungang

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  13. GLA-SE

    Lxo Ireland Designated Activity Company

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

  14. GLPG0187

    Lakefront Biotherapeutics NV

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  15. GME751

    Sandoz Pty Ltd

    Melanoma

    phase 1 small molecule active

    1 trial

  16. GMX1777

    Teva Pharma GmbH

    Solid Tumors and Lymphomas

    phase 1 small molecule terminated

    1 trial

  17. GPC3 and/or TGFβ targeting CAR-T cells

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  18. GPC3-CAR-T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab on hold

    1 trial

  19. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Melanoma

    phase 1 small molecule completed

    1 trial

  20. GSK5533524

    GlaxoSmithKline

    Neoplasms

    phase 1 small molecule active

    1 trial

  21. GV20-0251

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HCC - Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  22. GX15-070MS

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  23. GZ17-6.02

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  24. Gallium-68 NODAGA-JR11

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    phase 1 small molecule active

    1 trial

  25. Gallium-68 citrate

    United Therapeutics Europe Ltd

    Prostatic Neoplasms

    phase 1 small molecule completed

    1 trial

  26. Gemtuzumab Ozogamicin

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  27. Gilteritinib

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia With FLT3/ITD Mutation

    phase 1 small molecule active

    1 trial

  28. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 mab active

    1 trial

  29. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  30. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  31. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  32. HBV mRNA vaccine

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  33. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  34. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  35. HER-2/neu peptide vaccine

    Marker Therapeutics

    HER2-positive Breast Cancer

    phase 1 mab completed

    1 trial

  36. HER2 Tumor Vaccine

    The First People's Hospital of Lianyungang

    Adenocarcinoma - GEJ

    phase 1 mab active

    1 trial

  37. HER3-DXd

    Daiichi Sankyo

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  38. HMPL-306

    Hutchison Medipharma Limited

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  39. HPV-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 1 mab active

    1 trial

  40. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  41. HS-IT101 Injection

    Qingdao University

    Solid Tumor

    phase 1 small molecule active

    1 trial

  42. HTLP-onco-adult - A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies

    Pari Pharma GmbH

    hematologic malignancies ; acute myeloid leukemias

    phase 1 other active

    1 trial

  43. HW071021 Tablets

    Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  44. HW071021 Tablets

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  45. HWK-007

    Whitehawk Therapeutics

    Endometrial Cancer

    phase 1 small molecule active

    1 trial

  46. HWS116 Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  47. Health Promotion and Education

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 other completed

    1 trial

  48. Hema-NeoTIL01

    The First People's Hospital of Lianyungang

    Leukemia, Myeloid, Acute

    phase 1 mab active

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.